swelling of feet; migraines; increased swelling of feet with pitting - bilateral; fatigue; mild headache; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Jun2021 09:00 (Lot number: EW0191) at the age of 51 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "penicillin allergy" (unspecified if ongoing), notes: Known allergies: penicillin; "sulpha allergy" (unspecified if ongoing), notes: Known allergies: sulpha; "cashews allergy" (unspecified if ongoing), notes: Known allergies: FOOD: cashews, salmon, yeast; "salmon allergy" (unspecified if ongoing), notes: Known allergies: salmon; "yeast allergy" (unspecified if ongoing), notes: Known allergies: yeast; "migraines" (unspecified if ongoing), notes: Most prior medical issues (except for migraine) had been cleared.; "autoimmune type symptoms" (unspecified if ongoing), notes: prior history of autoimmune type symptoms including chronic fatigue; "chronic fatigue", stop date: 2009, notes: prior history of autoimmune type symptoms including chronic fatigue; "Borderline diabetes" (unspecified if ongoing), notes: hx of borderline diabetes. The patient's concomitant medications were not reported. Past drug history included: Lamictal, reaction(s): "known allergies: lamictal", notes: known allergies: lamictal; Versed, reaction(s): "known allergies: versed/demoral", notes: known allergies: versed/demerol; Demerol, reaction(s): "known allergies: versed/demerol", notes: known allergies: versed/demerol. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 08Jun2021, outcome "not recovered", described as "swelling of feet"; MIGRAINE (non-serious) with onset 08Jun2021, outcome "not recovered", described as "migraines"; CONDITION AGGRAVATED (non-serious) with onset 08Jun2021, outcome "not recovered", described as "increased swelling of feet with pitting - bilateral"; FATIGUE (non-serious) with onset 08Jun2021, outcome "not recovered", described as "fatigue"; HEADACHE (non-serious) with onset 08Jun2021, outcome "not recovered", described as "mild headache". Additional information: Patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Known allergies included lamictal, penicillin, sulpha, versed/demerol. FOOD: cashews, salmon, yeast. Other medical history included History of migraines, prior history of autoimmune type symptoms including chronic fatigue (resolved as of 2009), hx of borderline diabetes. Most prior medical issues (except for migraine) had been cleared and managed for many years through diet. Facility type vaccine was reported as Public Health Clinic/Military facility. Patient did not receive any other vaccine within four weeks. Patient experienced fatigue, swelling of feet, migraines (reported as one week post vaccination) and fatigue, increased swelling of feet with pitting - bilateral, mild headache (reported as two weeks post vaccination) on 08Jun2021. It was unknown if patient received any treatment for the adverse events or not (also reported as not received). The outcome of the events was not resolved.   No follow-up attempts are possible. No further information is expected.  Follow-Up (20Jul2021): Follow-up attempts are completed. No further information is expected.